GILD

Gilead Sciences Inc

May 18 • 04:00PM ET

129.67

+0.09 0.07 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: BMY PFE ABBV MRK AZN NVS LLY SNY AMGN TAK

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.64	EPS (ttm)	7.35	Insider Own	0.14%	Shs Outstand	1.24B	Perf Week	-2.88%
Market Cap	160.99B	Forward P/E	13.47	EPS next Y	9.63	Insider Trans	-18.44%	Shs Float	1.24B	Perf Month	-5.79%
Enterprise Value	173.27B	PEG	1.51	EPS next Q	-6.60	Inst Own	89.01%	Short Float	1.86%	Perf Quarter	-16.49%
Income	9.22B	P/S	5.41	EPS this Y	-92.52%	Inst Trans	-0.18%	Short Ratio	3.73	Perf Half Y	3.57%
Sales	29.79B	P/B	6.85	EPS next Y	1479.03%	ROA	16.35%	Short Interest	23.05M	Perf YTD	5.65%
Book/sh	18.93	P/C	16.40	EPS next 5Y	8.93%	ROE	43.19%	52W High	157.29 -17.56%	Perf Year	26.51%
Cash/sh	7.91	P/FCF	15.74	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	100.23 29.37%	Perf 3Y	65.80%
Dividend Est.	3.25 (2.50%)	EV/EBITDA	11.73	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	2.49% 2.38%	Perf 5Y	88.34%
Dividend TTM	3.19 (2.46%)	EV/Sales	5.82	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.24	Perf 10Y	56.46%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	39.87	Recom	1.66
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-1.74%	Beta	0.33	Target Price	160.56
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-5.40%	Rel Volume	0.84	Prev Close	129.58
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	1.35%	Avg Volume	6.18M	Price	129.67
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	5,181,152	Change	0.07%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)